Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

People overestimate benefits and underestimate risks of medical procedures, shows research

From major heart surgery to a course of minor drugs, people overestimate the benefits and underestimate the risks of a variety of medical procedures, according to new research.

25 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

25 Oct 2018

New $3.3 million grant will fund human cell atlas of type 1 diabetes

The mechanism leading to development of type 1 diabetes remains a mystery, hampering the ability to find new ways to prevent, treat or even cure this condition.

25 Oct 2018

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology

24 Oct 2018

New approach using 'cellular dust' offers hope for regenerative medicine

While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilized using extracellular vesicles (EVs), also known in the past as "cellular dust".

24 Oct 2018

Better blood pressure control may prevent organ damage related to hypertensive emergencies in diabetics

The most effective way to prevent life-threatening complications of extreme hypertension in African-Americans with diabetes is to better control their blood pressure, according to a Rutgers study, the largest of its kind.

24 Oct 2018

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

23 Oct 2018

Study uncovers new mechanism of action in a first-line drug for diabetes

For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.

23 Oct 2018

People with periodontal disease less likely to reach healthy blood pressure ranges

People with high blood pressure taking medication for their condition are more likely to benefit from the therapy if they have good oral health, according to new research in the American Heart Association's journal Hypertension.

22 Oct 2018

Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers

Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaking results from the CheckMate-142 trial reported at the ESMO 2018 Congress in Munich.

22 Oct 2018

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

EUSA Pharma welcomes the news that FOTIVDA (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology clinical practice guidelines for advanced renal cell carcinoma, anticipated to be published at the end of this year.

22 Oct 2018

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

A combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor, axitinib, significantly improves progression-free survival in previously untreated patients with advanced renal cell carcinoma in a phase 3 study, according to results presented at ESMO 2018 Congress.

22 Oct 2018

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis, Inc. today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors on the efficacy of cabozantinib in patients with advanced renal cell carcinoma (RCC). The findings are being presented this week at the European Society for Medical Oncology 2018 Congress being held October 19-23 in Munich, Germany.

22 Oct 2018

Not exercising is worse than smoking, diabetes or heart disease finds study

The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.

21 Oct 2018

New urea sorbent could speed up the development of wearable artificial kidney

There just aren't enough kidney transplants available for the millions of people with renal failure.

19 Oct 2018

Report predicts life expectancy in 2040, Spain comes out on top

A new report from the Institute for Health Metrics and Evaluation (IHME) states that people born and living in Spain, Japan, and China are likely to live longer than those born and living in the United States.

18 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Researchers find opportunity to control salt-sensitive hypertension without exercising

Couch potatoes rejoice -- there might be a way to get the blood pressure lowering benefits of exercise in pill form.

16 Oct 2018

Study highlights need for increased support for alcohol-related liver disease patients

Two in three ALD patients admitted to an intensive care unit (ICU) survived for less than a year afterwards, the study shows.

15 Oct 2018

Nephrology News and Research

Further Reading

People overestimate benefits and underestimate risks of medical procedures, shows research

Head and neck cancer survivors more likely to commit suicide

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

New $3.3 million grant will fund human cell atlas of type 1 diabetes

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

New approach using 'cellular dust' offers hope for regenerative medicine

Better blood pressure control may prevent organ damage related to hypertensive emergencies in diabetics

Lowering systolic blood pressure does not damage the kidneys, shows study

Study uncovers new mechanism of action in a first-line drug for diabetes

People with periodontal disease less likely to reach healthy blood pressure ranges

Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Not exercising is worse than smoking, diabetes or heart disease finds study

New urea sorbent could speed up the development of wearable artificial kidney

Report predicts life expectancy in 2040, Spain comes out on top

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Researchers find opportunity to control salt-sensitive hypertension without exercising

Study highlights need for increased support for alcohol-related liver disease patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News